Home
Loading

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

Get in touch

  • Contact

  • Request a demo

  • Request data updates

  • Add a company

Research

  • Companies

  • Investors

  • People

aVenture

  • Sitemap

  • Feature requests

Member

Backed by

© aVenture Investment Company, 2026. All rights reserved.

San Francisco, CA, USA

Privacy Policy

aVenture Investment Company ("aVenture") is an independent research platform providing detailed analysis and data on startups, venture capital investments, and key industry individuals. It is not a registered investment adviser, broker-dealer, or investment advisor and does not provide investment advice or recommendations. The data provided by aVenture does not constitute recommendations or advice, whether by methodology, analysis, AI-generated content, or a statement written by a staff member of aVenture.

aVenture is not affiliated with any of the people, companies, organizations, government agencies, regulatory bodies, or investment funds we provide coverage for on this site unless explicitly stated otherwise. Users assume full responsibility for decisions made based on information obtained from this platform. Links to external websites do not imply endorsement or affiliation with aVenture. Any links that provide the ability to invest in a primary or secondary transaction in a company are for convenience only and do not constitute solicitations or offers to buy or sell an investment. Investors should exercise heightened precaution and due diligence when investing in private companies, especially those not independently audited.

While we strive to provide valuable insights with objectivity and professional diligence, we cannot guarantee the accuracy of the information provided on our platform. Before making any investment decisions, you should verify the accuracy of all pertinent details for your decision. To the fullest extent permitted by law, aVenture shall not be liable for any direct, indirect, incidental, consequential, or financial damages arising from use of this site, whether by consumers of its contents directly or by persons or organizations covered by our research, even if we are advised of the possibility. Our best-efforts processes and correction request forms do not create a warranty or duty of care.

Profiles on this platform may include content generated in part by large language models (LLMs, artificial intelligence) that aggregate publicly available sources (e.g., SEC EDGAR, public filings, press releases). Source attribution is provided where known; always verify statements and claims here against original sources before relying on any data. Content on our site may contain inaccuracies, omissions, or what are commonly called 'hallucinations' if generated in part or in full by AI / LLMs. The risk can also exist even when content is written by a human, as internal and third-party sources may also have inaccuracies for the same or different reasons. While we randomly audit a proportion of content, this is not exhaustive.

We recommend that an independent auditor be hired to verify the accuracy of the information before relying on it for any sensitive decisions. By accessing this platform, you agree not to rely solely on any information generated by AI, aggregated, or sourced or written otherwise on this site, for investment, financial, or other decisions. aVenture assumes no responsibility for inaccuracies, omissions, or hallucinations. You must independently verify all data from primary sources. Use of this platform constitutes your waiver of claims for reliance-based damages, including negligent misrepresentation. To report an error, request a correction, or dispute information about a company or individual, contact us via our request data updates form.

Loading homepage
Loading
Home›Research›Companies

Companies

Loading
Home›
Research›
Companies›
Calando Pharmaceuticals
AddedFeb 15, 2024
UpdatedJun 18, 2026
Calando Pharmaceuticals

Calando Pharmaceuticals

Acquired

Calando Pharmaceuticals Inc. develops nanoparticle therapeutics using nanobiotechnology for RNA interference.

HQ
Pasadena, CA, US
Founded
2005
Overview
Compare
Fundraising
Employees
Website

Calando Pharmaceuticals Inc. was founded with the mission to revolutionize drug delivery systems using nanobiotechnology, specifically focusing on RNA interference (RNAi) therapies. The company's core vision is to extend the reach of RNAi therapy by developing effective and safe systemic delivery methods. Calando's flagship product, CALAA-01, targets cancer and utilizes their proprietary RONDEL delivery system to enhance the efficacy of siRNA-based treatments. Their market focus is primarily on clinical-stage nanoparticle therapeutics for serious diseases.

Notable affiliated individuals include Mark E. Davis from the California Institute of Technology, who has contributed significantly to the development of Calando's technologies. The company has attracted attention from investors interested in cutting-edge biotechnology solutions. Key achievements include advancing CALAA-01 into clinical trials, demonstrating the potential of their RONDEL system in effectively delivering RNAi therapies. Overall, Calando Pharmaceuticals has made a substantial impact in the field of nanobiotechnology and RNAi, pushing the boundaries of targeted cancer treatment.

Calando Pharmaceuticals - Similar Companies

NantBio logo

NantBio

Camino Pharma logo

Camino Pharma

caminopharma.com

Locanabio logo

Locanabio

Nextrna Therapeutics logo

Nextrna Therapeutics

Advanced NanoTherapies logo

Advanced NanoTherapies

Cour Pharmaceuticals Development logo

Cour Pharmaceuticals Development

courpharma.com

Quark Pharmaceuticals logo

Quark Pharmaceuticals

Silence Therapeutics logo

Silence Therapeutics

Sanegene Bio logo

Sanegene Bio

sanegenebio.com

Ribon Therapeutics logo

Ribon Therapeutics

ribontx.com

Atalanta Therapeutics logo

Atalanta Therapeutics

atalantatx.com

Vali Nanomedical logo

Vali Nanomedical

Nanocan Therapeutics logo

Nanocan Therapeutics

ReviR Therapeutics logo

ReviR Therapeutics

revirtx.com

Orbital Therapeutics logo

Orbital Therapeutics

Calando Pharmaceuticals - Quick Facts

Who are Calando Pharmaceuticals' competitors?

Companies similar to Calando Pharmaceuticals include NantBio, Camino Pharma, Locanabio and Nextrna Therapeutics.

When was Calando Pharmaceuticals founded?

Calando Pharmaceuticals was founded in 2005.

Where is Calando Pharmaceuticals' headquarters located?

Calando Pharmaceuticals' headquarters is located in Pasadena, CA, US.

When was Calando Pharmaceuticals' last funding round?

Calando Pharmaceuticals' most recent funding round was for $1M (USD) in January 2011.

How much has Calando Pharmaceuticals raised to-date?

As of Jan 18, 2011, Calando Pharmaceuticals has raised a total of $11M (USD).

Calando Pharmaceuticals - Classification

Ownership
  • Venture Capital
Technology
  • Nanobiotechnology
Geographic Exposure
  • United States
Revenue
  • Recurring
Customer
  • Enterprise
Main Product
  • RNAI Therapeutics
Tags
  • Biotech
NAICS
  • 320000Manufacturing
  • 325400Pharmaceutical and Medicine Manufacturing
  • 325000Chemical Manufacturing
  • 325410Pharmaceutical and Medicine Manufacturing
  • 325412Pharmaceutical Preparation Manufacturing
SIC
  • 2800Chemicals And Allied Products
  • 2830Drugs
  • 2834Pharmaceutical Preparations
Show 12 more industry codes
NAICS
  • 540000Professional, Scientific, and Technical Services
  • 541714Research and Development in Biotechnology (except Nanobiotechnology)
  • 620000Health Care and Social Assistance
  • 541000Professional, Scientific, and Technical Services
  • 541700Scientific Research and Development Services
  • 541710Research and Development in the Physical, Engineering, and Life Sciences
SIC
  • 8000Health Services
  • 8700Engineering, Accounting, Research, Management, And Related Services
  • 8040Offices And Clinics Of Other Health Practitioners
  • 8730Research, Development, And Testing Services
  • 8049Offices And Clinics Of Health Practitioners, Not Elsewhere Classified
  • 8731Commercial Physical and Biological Research